摘要
研究多西他赛联合奥沙利铂和替吉奥一线对晚期胃癌的效果及安全性。采用"电脑随机法"将40例晚期胃癌患者分为观察组和对照组。观察组实施多西他赛联合奥沙利铂和替吉奥一线治疗;对照组实施奥沙利铂治疗。分析两组治疗效果、生活质量评分、疾病进展时间和生存时间、免疫功能指标、不良反应、炎性指标,结果显示,观察组各项指标均优于对照组,P<0. 05,说明多西他赛联合奥沙利铂和替吉奥一线对晚期胃癌的效果显著,同时具有较高安全性。
The efficacy and safety of docetaxel combined with oxaliplatin and tegiol in the treatment of advanced gastric cancer were studied.40 patients with advanced gastric cancer were divided into two groups by “computer random method”.The observation group received first-line treatment of docetaxel combined with oxaliplatin and tegio , and the control group received oxaliplatin.The therapeutic effect, quality of life score and disease progression time of the two groups were analyzed.And survival time, immune function index, adverse reactions.The indexes of the observation group were better than those of the control group ( P <0.05).Docetaxel combined with oxaliplatin and tegiol is effective and safe in the treatment of advanced gastric cancer.
作者
邱仙土
林伟
陈金坤
黄少雄
郭健
徐锐
QIU Xiantu;LIN Wei;CHEN Jinkun;HUANG Shaoxiong;GUO Jian;XU Rui(Department of Gastrointestinal Surgery,The Affiliated Hospital of Putian University,Putian Fujian 351100,China)
出处
《莆田学院学报》
2019年第2期21-25,共5页
Journal of putian University
基金
福建省卫生厅青年科研课题(JAT160429)
关键词
多西他赛
奥沙利铂
替吉奥
晚期胃癌
效果
docetaxel
oxaliplatin
tegiol
advanced gastric cancer
efficacy
